Across TCGA pan-cancer cohorts, CCDC162P RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of CCDC162P’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where CCDC162P RNA is repressed in tumor relative to normal tissue. In most cancer types CCDC162P is over-expressed in tumor, although a few such as KIRP and KICH show the opposite, repressed pattern.
KIRP, HNSC, and KICH are the cancer types where CCDC162P tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCDC162P RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.